RPM International Surges 10.2% After Reporting Better-than-Expected Earnings
ByAinvest
Thursday, Jul 24, 2025 10:42 am ET1min read
ARAI--
West Pharmaceutical Services Inc. (WST) also reported strong quarterly results, with adjusted EPS of $1.84, up from $1.52 a year ago. This exceeded the mean expectation of analysts, who had forecast EPS of $1.51. Revenue rose 9.2% to $766.50 million, surpassing the expected $727.45 million. The company's quarterly net income was $131.8 million. Shares of West Pharmaceutical Services Inc. rose by 3.9% this quarter and lost 30.6% so far this year. Analysts have a "buy" rating with 11 "strong buy" or "buy" recommendations, 4 "hold" recommendations, and no "sell" recommendations. The median 12-month price target for WST is $273.50, up 16.9% from the last closing price of $227.31 [2].
These positive results come amidst a broader market trend where several other major stocks, including ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer, have also shown gains.
References:
1. [1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KU:0-rpm-international-inc-reports-results-for-the-quarter-ended-may-31-earnings-summary/
2. [2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KK:0-west-pharmaceutical-services-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/
ASGN--
BE--
CRL--
DB--
RPM International reported better-than-expected quarterly EPS and sales, with shares jumping 10.2% to $124.46. Other big stocks recording gains include West Pharmaceutical Services, ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer.
RPM International Inc. (RPM) reported better-than-expected quarterly earnings and revenue, with adjusted earnings per share (EPS) of $1.72, up from $1.56 a year ago. This figure exceeded the mean expectation of analysts, who had forecast EPS of $1.59. Revenue rose 3.7% to $2.08 billion, surpassing the expected $2.01 billion. The company's quarterly net income was $225.51 million. Shares of RPM International Inc. rose by 2.8% this quarter and lost 8.2% so far this year. Analysts have a "buy" rating with 10 "strong buy" or "buy" recommendations, 7 "hold" recommendations, and 1 "sell" recommendation. The median 12-month price target for RPM is $124.00, up 8.9% from the last closing price of $112.95 [1].West Pharmaceutical Services Inc. (WST) also reported strong quarterly results, with adjusted EPS of $1.84, up from $1.52 a year ago. This exceeded the mean expectation of analysts, who had forecast EPS of $1.51. Revenue rose 9.2% to $766.50 million, surpassing the expected $727.45 million. The company's quarterly net income was $131.8 million. Shares of West Pharmaceutical Services Inc. rose by 3.9% this quarter and lost 30.6% so far this year. Analysts have a "buy" rating with 11 "strong buy" or "buy" recommendations, 4 "hold" recommendations, and no "sell" recommendations. The median 12-month price target for WST is $273.50, up 16.9% from the last closing price of $227.31 [2].
These positive results come amidst a broader market trend where several other major stocks, including ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer, have also shown gains.
References:
1. [1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KU:0-rpm-international-inc-reports-results-for-the-quarter-ended-may-31-earnings-summary/
2. [2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KK:0-west-pharmaceutical-services-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet